NYU Comprehensive Epilepsy Center
New York, New York, United States
Neurologist in New York City, New York
223 E 34th St, New York, NY 10016
About NYU Comprehensive Epilepsy Center
"Don’t delay your care: you can schedule in-office appointments or video visits with NYU Langone doctors online. Every precaution is in place to ensure our facilities are safe so you can get the care you need. Visit our website for more details."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eisai Inc.
4
Marinus Pharmaceuticals
3
Takeda
3
Jazz Pharmaceuticals
2
Stoke Therapeutics, Inc
2
The Epilepsy Study Consortium
2
Engage Therapeutics, Inc.
1
NYU Langone Health
1
Neurelis, Inc.
1
Neurona Therapeutics
1
Novartis
1
Clinical Trials at NYU Comprehensive Epilepsy Center
During the past decade, NYU Comprehensive Epilepsy Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on
average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
2006-02-13
2009-05-20
Completed
356
Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
2007-03-15
2010-05-14
Terminated
286
To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
2008-05-01
2011-01-01
Completed
389
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
2010-06-01
2011-09-01
Completed
93
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
2013-07-31
2021-10-31
Completed
437
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NYU Comprehensive Epilepsy Center" #1 sponsor was "Eisai Inc." with 4 trials, followed by "Marinus Pharmaceuticals" with 3 trials
sponsored, "Takeda" with 3 trials sponsored, "Jazz Pharmaceuticals" with 2 trials sponsored and "Stoke Therapeutics, Inc"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Comprehensive Epilepsy Center"
#1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator and "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at NYU Comprehensive Epilepsy Center
According to Clinical.Site data, the most researched conditions in "NYU Comprehensive Epilepsy Center" are
"Epilepsy" (4 trials), "Dravet Syndrome" (3 trials), "Tuberous Sclerosis Complex" (3 trials), "Dravet Syndrome (DS)" (2 trials) and "Lennox Gastaut Syndrome" (2 trials). Many other conditions were trialed in "NYU Comprehensive Epilepsy Center" in a lesser frequency.
Clinical Trials Intervention Types at NYU Comprehensive Epilepsy Center
Most popular intervention types in "NYU Comprehensive Epilepsy Center" are "Drug" (22 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Soticlestat" (3 trials), "Rufinamide" (2 trials), "CX-8998" (1 trials) and "E2007 (perampanel)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NYU Comprehensive Epilepsy Center
The vast majority of trials in "NYU Comprehensive Epilepsy Center" are
25 trials for "All" genders.
Clinical Trials Status at NYU Comprehensive Epilepsy Center
Currently, there are NaN active trials in "NYU Comprehensive Epilepsy Center".
undefined are not yet recruiting,
8 are recruiting,
2 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 12 completed trials in NYU Comprehensive Epilepsy Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in NYU Comprehensive Epilepsy Center, 2 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".